For example, RELT is a good prognostic indicator for small-cell lung cancer [27], yet conversely, it can promote NF-κB activation in multiple myeloma cells [20] and in ESCC [19] and inhibit Caspase 3 cleavage in ESCC [19]. Here, NFKB1 is linked to plasma cell myeloma.